Search

everythinglearnresearchcommunity

for

Search:↓

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

The document concludes that accurate diagnosis of ichthyosis is crucial for treatment and genetic advice, and ongoing research is needed for better therapies.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Cytokeratin 19 and cytokeratin 15 are key markers for monitoring the quality and self-renewing potential of engineered skin.

Hair grows faster in the morning and is more vulnerable to damage from radiation due to the internal clock in hair follicle cells.

Children with atopic dermatitis often have sleep problems, affecting their growth and behavior.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

We need more research to better understand human hair follicle stem cells for improved treatments for hair loss and skin cancer.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Hair elemental analysis could be useful for health and exposure assessment but requires more standardization and research.

Lower SHBG levels may increase the risk of PCOS.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Platelet-rich plasma might help tissue regeneration in dentistry, but results vary and more research is needed.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

White lupin uses specific genes to grow root hairs and access phosphorus when it's scarce.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Multiphoton microscopy is a promising tool for detailed skin imaging and could improve patient care if its challenges are addressed.